Screening and diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 2005 Jun;34(2):385-402, ix-x
Date
04/27/2005Pubmed ID
15850849DOI
10.1016/j.ecl.2005.02.001Scopus ID
2-s2.0-18044378555 (requires institutional sign-in at Scopus site) 123 CitationsAbstract
Screening studies in high-risk populations have suggested that Cushing's syndrome is more common than previously appreciated. Patients who have specific signs and symptoms or clinical diagnoses known to be associated with hypercortisolism should be considered for screening. The measurement of late-night salivary cortisol provides the most sensitive method for screening, and urine-free cortisol and low-dose dexamethasone suppression testing may be used for confirmation of the diagnosis of endogenous hypercortisolism
Author List
Findling JW, Raff HAuthors
James W. Findling MD Professor in the Medicine department at Medical College of WisconsinHershel Raff PhD Professor in the Academic Affairs department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Cushing SyndromeDiagnostic Techniques, Endocrine
Humans
Mass Screening
